| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |